Primorigen Biosciences Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Primorigen Biosciences General Information

Description

Developer of antibodies and proteins intended to be used for cellular characterization and preclinical research. The company develops cell culture matrices, antibodies, recombinant proteins, spots on dots, primary neuronal cells and mesenchymal stem cells, providing clients with innovative services for stem cell maintenance, proliferation, differentiation and large-scale production.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Nucleus Biologics
Primary Office
  • 510 Charmany Drive
  • Suite 257
  • Madison, WI 53719
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Primorigen Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 06-Aug-2019 00.00 Completed Generating Revenue
4. Grant 01-Apr-2015 00.000 00.00 Completed Generating Revenue
3. Grant 27-Mar-2013 00.00 00.00 Completed Generating Revenue
2. Grant 08-Jul-2012 $344K $2.5M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Aug-2006 $2.5M $2.5M Completed Startup
To view Primorigen Biosciences’s complete valuation and funding history, request access »

Primorigen Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Chuck Oehler Founder, Chairman & President
You’re viewing 1 of 2 executive team members. Get the full list »

Primorigen Biosciences Board Members (1)

Name Representing Role Since
Chuck Oehler Primorigen Biosciences Founder, Chairman & President 000 0000
To view Primorigen Biosciences’s complete board members history, request access »

Primorigen Biosciences Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Louisiana Funds Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Primorigen Biosciences’s complete investors history, request access »